This first-line protocol addresses patients with relapsing polychondritis who develop ocular inflammation in the form of episcleritis or scleritis without signs of severity. In this presentation, a combined local and systemic approach is indicated.
Management centers on local treatment combined with systemic anti-inflammatory therapy. The full protocol specifies the agents, selection criteria, and sequencing for this specific ocular presentation.
In the specific case of scleritis without signs of severity and episcleritis, systemic treatment with NSAIDs may be effective.
The management of the active phase of inflammatory manifestations is based on local treatment, combined with systemic treatment during the following manifestations: scleritis, ulcerated keratitis, posterior uveitis with or without retinal vasculitis.
DOI: 10.1016/j.revmed.2023.05.005
View source ↗